Clinical Trial Update: Low-dose Cortisol in Chronic Posttraumatic Stress Disorder [NA]

View source ↗

Summary

A University of Zurich trial evaluating low-dose cortisol for chronic posttraumatic stress disorder has been terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Low-dose cortisol (cortisol)

Snippet

Sponsor: University of Zurich | Conditions: Posttraumatic Stress Disorder | NA | Status: TERMINATED